Global Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Regional Outlook and Forecast, 2022 - 2028

The Global Spinal Muscular Atrophy Treatment Market size is expected to reach $11.4 billion by 2028, rising at a market growth of 17.8% CAGR during the forecast period.

An extremely uncommon genetic condition called spinal muscular atrophy (SMA) damages the area of the central nervous system that regulates voluntary muscle movements. SMA is a neurological autosomal recessive genetic condition marked by muscular atrophy and deterioration. It is among the most prevalent genetic diseases with devastating symptoms and the main genetic cause of newborn mortality.

SMA is a genetic condition that runs in families. If the child has SMA, it is likely due to the presence of two faulty genes, one from each parent, in their body. Their system won't be capable of producing a particular form of protein as a result, the cells that govern muscles perish without it. If just one of the parents passes on a defective gene to the child, they will not develop SMA but they will be carriers of the condition.

The child might carry the damaged gene onto their offspring when they are adults. Depending on the type, spinal muscular atrophy symptoms might be very different. The most severe symptoms of Type 1 SMA in children are typically present during the initial six months of their lives and are more severe.

Those with milder kinds may not exhibit symptoms until the children are 18 months or older since they are less severe. Scoliosis, respiratory issues, swallowing and issues in feeding, delayed gross motor abilities, decreased muscle tone and muscle weakness, limited mobility, and delayed tongue motions are all possible signs of SMA.

COVID-19 Impact Analysis

Due to severe lockdown procedures and limited human movement, the COVID-19 pandemic has negatively impacted the spinal muscular atrophy treatment market. Since the majority of funding was used for COVID-19 vaccine production, the money obtained for Research and development activities and medication research for SMA was decreasing. Access to care for people with spinal muscular atrophy (SMA) was adversely affected by the pandemic. For instance, Cure SMA, a non-profit organization, voluntary-driven, dedicated solely to eliminating SMA, launched a poll in an attempt to assess the impact of the pandemic on the SMA community.

Market Growth Factors

Growing R&D Activities For The Spinal Muscular Atrophy Treatment

The prevalence and knowledge of spinal muscular atrophy have significantly increased, which is driving the demand for effective therapy options that improve patient outcomes. There have been two significant product introductions in the field of gene therapy recently. For a very long time, there was no cure for the rare condition spinal muscular atrophy, which frequently resulted in newborns and young children dying.

Increasing Reimbursement Access To Patients

One of the major trends in spinal muscular atrophy (SMA) is expanding the opportunity for the reimbursement of costly medications globally in several countries. This is predicted to have a favorable impact on the uptake of costly gene therapies. France, Germany, Austria, and Italy are a few of the nations that have given all patients access to services that are reimbursed, and Israel and Hong Kong have done the same.

Market Restraining Factors

Extremely High Costs Of The Approved Products

The high cost of treating rare genetic illnesses is one of the main factors that has constrained the expansion of the treatment facility. For instance, Spinraza is expected to cost US$ 708,000 in the first year and US$ 354,000 in each year after that, totaling US$ 3.9 million for the expense of treatment over a ten-year period. While a single Novartis therapy for Zolgensma is expected to cost US$ 2.1 million. By comparison, risdiplam can cost up to $340,000 annually. These expenses can undoubtedly cause serious problems for both patients and their families as well as healthcare professionals.

Type Outlook

Based on type, the spinal muscular atrophy treatment market is categorized into type 1, type 2, type 3, and type 4. The Type 1 segment garnered the highest revenue share in the spinal muscular atrophy treatment market in 2021. The significant prevalence rate is responsible for this growth. About half of all newborn infants with SMA have this kind of SMA, making it more widespread. A number of treatments, notably Zolgensma (onasemnogene abeparvovec-xioi), have received FDA approval for the treatment of type-1 patients.

Treatment Type Outlook

On the basis of treatment type, the spinal muscular atrophy treatment market is divided into gene therapy and drug. The drug segment acquired the largest revenue share in the spinal muscular atrophy treatment market in 2021. The segment is expanding because of the low cost of drug research and development as well as the simplicity of access relative to other treatments. Presently, three major FDA-approved drugs for the treatment of SMA are available on the market.

Route Of Administration Outlook

On the basis of route of administration, the spinal muscular atrophy treatment market is classified into oral and injection. The oral segment recorded a substantial revenue share in the spinal muscular atrophy treatment market in 2021. This is due to benefits like non-invasiveness, simplicity of pain avoidance, digestion, adaptability, and fewer side effects as opposed to other methods of administration methods that are linked with it.

Spinal Muscular Atrophy Treatment Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 3.7 Billion
Market size forecast in 2028	USD 11.4 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 17.8% from 2022 to 2028
Number of Pages	252
Number of Tables	440
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Type, Route of Administration, Treatment Type, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Australia, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Growing R&D Activities For The Spinal Muscular Atrophy Treatment Increasing Reimbursement Access To Patients
Restraints	Extremely High Costs Of The Approved Products

Regional Outlook

Based on region, the spinal muscular atrophy treatment market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the largest revenue share in the spinal muscular atrophy treatment market in 2021. The key drivers of the region's domination are the increasing incidence of SMA conditions and rising spending on treatment supplies. For instance, between 10,000 and 25,000 youngsters and adults reside in the United States who have SMA.

Free Valuable Insights: Global Spinal Muscular Atrophy Treatment Market size to reach USD 11.4 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Biogen, Inc., Novartis AG, Ionis Pharmaceuticals, Inc., PTC Therapeutics, Inc., NMD Pharma A/S, Scholar Rock, Inc. (Scholar Rock Holding Corporation), Cytokinetics, Inc., Biohaven Pharmaceutical Holding Company Ltd. (Pfizer, Inc.), Astellas Pharma, Inc., and F. Hoffmann-La Roche Ltd. (Genentech, Inc.)

Strategies deployed in Spinal Muscular Atrophy Treatment Market

• May-2022: Genentech received approval from FDA for Evrysdi (risdiplam) for use in babies under two months with SMA. Evrysdi (risdiplam) is an early treatment for SMA and can be taken at home.
• Feb-2022: Biohaven signed an agreement with Bristol Myers Squibb, a US-based pharmaceutical company primarily into developing, and discovering therapeutics. The agreement involves transferring the development and commercialization rights of taldefgrobep alfa, a phase-3 ready anti-myostatin adnectin. This transfer of rights broadened Biohaven's product portfolio of psychiatric, neuroinflammatory, and neurologic treatments.
• Mar-2021: PTC Therapeutics got approval from European Commission for Evrysdi, a liquid dose, developed to treat Spinal Muscular Atrophy, which can be taken at home, and can be taken by both children and adults.
• Mar-2021: PTC extended its partnership with Spinal Muscular Atrophy (SMA) Foundation, a non-profit organization focused on developing treatments for SMA. The expansion aims to reinforce drug discovery and development research focused on regenerative medicine.
• Oct-2020: Ionis completed the acquisition of Akcea Therapeutics, a biopharmaceutical firm engaged in developing and marketing therapies and medicines focused on treating patients with rare diseases. This acquisition enables Ionis to generate value from Akcea's underway therapies and products.
• Jun-2020: PTC took over Censa Pharmaceuticals, a biopharmaceutical company primarily into developing CNSA-001 (sepiapterin), a pharmacological treatment meant for orphan metabolic diseases. This acquisition reinforced PTC's existing rare disease portfolio.
• May-2020: NMD Pharma expanded its geographical footprint by establishing a new subsidiary, NMD Pharma US, Inc. in the United States. This expansion aligns with NMD's growth strategy and enables them to further reinforce and expand their pipeline in rare neuromuscular diseases.
• Mar-2020: Novartis received approval for Zolgensma from the Japanese Ministry of Health, Labour, and Welfare. Zolgensma is a gene therapy for patients below the age of two years suffering from spinal muscular atrophy. A single dose of Zolgensma is capable of making a significant positive impact on the patient's condition.
• Nov-2018: Genentech acquired Jecure Therapeutics, a biotech company focused on developing drugs for inflammatory diseases. The acquisition complemented Genentech's proficiency in NLRP3 biology and enabled them to better take care of patients with inflammatory diseases.
• Aug-2018: PTC acquired Agilis Biotherapeutics, a biotechnology company primarily developing DNA therapeutics focused on rare diseases. This acquisition lines up with PTC's aim of being a leader in rare disorders treatment.
• May-2018: Novartis acquired AveXis, a biotechnology company providing treatment services for rare neurological genetic disorders. This acquisition aligns with Novartis's plan to provide life-changing innovation for unmet medical requirements and further complements its expanding pipeline of gene therapies focused on the treatment of diseases ranging from SMA to blindness.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Type 1
• Type 2
• Type 3
• Type 4

By Route of Administration

• Injection
• Oral

By Treatment Type

• Drug
  • Spinraza
  • Zolgensma (AVXS-101)
  • Evrysdi
  • Others
• Gene Therapy

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Biogen, Inc.
• Novartis AG
• Ionis Pharmaceuticals, Inc.
• PTC Therapeutics, Inc.
• NMD Pharma A/S
• Scholar Rock, Inc. (Scholar Rock Holding Corporation)
• Cytokinetics, Inc.
• Biohaven Pharmaceutical Holding Company Ltd. (Pfizer, Inc.)
• Astellas Pharma, Inc.
• F.Hoffmann-La Roche Ltd. (Genentech, Inc.)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Spinal Muscular Atrophy Market, by Type
1.4.2 Global Spinal Muscular Atrophy Market, by Route of Administration
1.4.3 Global Spinal Muscular Atrophy Market, by Treatment Type
1.4.4 Global Spinal Muscular Atrophy Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Spinal Muscular Atrophy Market

Chapter 4. Global Spinal Muscular Atrophy Treatment Market by Type
4.1 Global Type 1 Market by Region
4.2 Global Type 2 Market by Region
4.3 Global Type 3 Market by Region
4.4 Global Type 4 Market by Region

Chapter 5. Global Spinal Muscular Atrophy Treatment Market by Route of Administration
5.1 Global Injection Market by Region
5.2 Global Oral Market by Region

Chapter 6. Global Spinal Muscular Atrophy Treatment Market by Treatment Type
6.1 Global Drug Market by Region
6.2 Global Spinal Muscular Atrophy Treatment Market by Drug Type
6.2.1 Global Spinraza Market by Region
6.2.2 Global Zolgensma (AVXS-101) Market by Region
6.2.3 Global Evrysdi Market by Region
6.2.4 Global Others Market by Region
6.3 Global Gene Therapy Market by Region

Chapter 7. Global Spinal Muscular Atrophy Treatment Market by Region
7.1 North America Spinal Muscular Atrophy Treatment Market
7.1.1 North America Spinal Muscular Atrophy Treatment Market by Type
7.1.1.1 North America Type 1 Market by Country
7.1.1.2 North America Type 2 Market by Country
7.1.1.3 North America Type 3 Market by Country
7.1.1.4 North America Type 4 Market by Country
7.1.2 North America Spinal Muscular Atrophy Treatment Market by Route of Administration
7.1.2.1 North America Injection Market by Country
7.1.2.2 North America Oral Market by Country
7.1.3 North America Spinal Muscular Atrophy Treatment Market by Treatment Type
7.1.3.1 North America Drug Market by Country
7.1.3.2 North America Spinal Muscular Atrophy Treatment Market by Drug Type
7.1.3.2.1 North America Spinraza Market by Country
7.1.3.2.2 North America Zolgensma (AVXS-101) Market by Country
7.1.3.2.3 North America Evrysdi Market by Country
7.1.3.2.4 North America Others Market by Country
7.1.3.3 North America Gene Therapy Market by Country
7.1.4 North America Spinal Muscular Atrophy Treatment Market by Country
7.1.4.1 US Spinal Muscular Atrophy Treatment Market
7.1.4.1.1 US Spinal Muscular Atrophy Treatment Market by Type
7.1.4.1.2 US Spinal Muscular Atrophy Treatment Market by Route of Administration
7.1.4.1.3 US Spinal Muscular Atrophy Treatment Market by Treatment Type
7.1.4.1.3.1 US Spinal Muscular Atrophy Treatment Market by Drug Type
7.1.4.2 Canada Spinal Muscular Atrophy Treatment Market
7.1.4.2.1 Canada Spinal Muscular Atrophy Treatment Market by Type
7.1.4.2.2 Canada Spinal Muscular Atrophy Treatment Market by Route of Administration
7.1.4.2.3 Canada Spinal Muscular Atrophy Treatment Market by Treatment Type
7.1.4.2.3.1 Canada Spinal Muscular Atrophy Treatment Market by Drug Type
7.1.4.3 Mexico Spinal Muscular Atrophy Treatment Market
7.1.4.3.1 Mexico Spinal Muscular Atrophy Treatment Market by Type
7.1.4.3.2 Mexico Spinal Muscular Atrophy Treatment Market by Route of Administration
7.1.4.3.3 Mexico Spinal Muscular Atrophy Treatment Market by Treatment Type
7.1.4.3.3.1 Mexico Spinal Muscular Atrophy Treatment Market by Drug Type
7.1.4.4 Rest of North America Spinal Muscular Atrophy Treatment Market
7.1.4.4.1 Rest of North America Spinal Muscular Atrophy Treatment Market by Type
7.1.4.4.2 Rest of North America Spinal Muscular Atrophy Treatment Market by Route of Administration
7.1.4.4.3 Rest of North America Spinal Muscular Atrophy Treatment Market by Treatment Type
7.1.4.4.3.1 Rest of North America Spinal Muscular Atrophy Treatment Market by Drug Type
7.2 Europe Spinal Muscular Atrophy Treatment Market
7.2.1 Europe Spinal Muscular Atrophy Treatment Market by Type
7.2.1.1 Europe Type 1 Market by Country
7.2.1.2 Europe Type 2 Market by Country
7.2.1.3 Europe Type 3 Market by Country
7.2.1.4 Europe Type 4 Market by Country
7.2.2 Europe Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.2.1 Europe Injection Market by Country
7.2.2.2 Europe Oral Market by Country
7.2.3 Europe Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.3.1 Europe Drug Market by Country
7.2.3.2 Europe Spinal Muscular Atrophy Treatment Market by Drug Type
7.2.3.2.1 Europe Spinraza Market by Country
7.2.3.2.2 Europe Zolgensma (AVXS-101) Market by Country
7.2.3.2.3 Europe Evrysdi Market by Country
7.2.3.2.4 Europe Others Market by Country
7.2.3.3 Europe Gene Therapy Market by Country
7.2.4 Europe Spinal Muscular Atrophy Treatment Market by Country
7.2.4.1 Germany Spinal Muscular Atrophy Treatment Market
7.2.4.1.1 Germany Spinal Muscular Atrophy Treatment Market by Type
7.2.4.1.2 Germany Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.4.1.3 Germany Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.4.1.3.1 Germany Spinal Muscular Atrophy Treatment Market by Drug Type
7.2.4.2 UK Spinal Muscular Atrophy Treatment Market
7.2.4.2.1 UK Spinal Muscular Atrophy Treatment Market by Type
7.2.4.2.2 UK Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.4.2.3 UK Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.4.2.3.1 UK Spinal Muscular Atrophy Treatment Market by Drug Type
7.2.4.3 France Spinal Muscular Atrophy Treatment Market
7.2.4.3.1 France Spinal Muscular Atrophy Treatment Market by Type
7.2.4.3.2 France Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.4.3.3 France Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.4.3.3.1 France Spinal Muscular Atrophy Treatment Market by Drug Type
7.2.4.4 Russia Spinal Muscular Atrophy Treatment Market
7.2.4.4.1 Russia Spinal Muscular Atrophy Treatment Market by Type
7.2.4.4.2 Russia Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.4.4.3 Russia Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.4.4.3.1 Russia Spinal Muscular Atrophy Treatment Market by Drug Type
7.2.4.5 Spain Spinal Muscular Atrophy Treatment Market
7.2.4.5.1 Spain Spinal Muscular Atrophy Treatment Market by Type
7.2.4.5.2 Spain Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.4.5.3 Spain Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.4.5.3.1 Spain Spinal Muscular Atrophy Treatment Market by Drug Type
7.2.4.6 Italy Spinal Muscular Atrophy Treatment Market
7.2.4.6.1 Italy Spinal Muscular Atrophy Treatment Market by Type
7.2.4.6.2 Italy Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.4.6.3 Italy Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.4.6.3.1 Italy Spinal Muscular Atrophy Treatment Market by Drug Type
7.2.4.7 Rest of Europe Spinal Muscular Atrophy Treatment Market
7.2.4.7.1 Rest of Europe Spinal Muscular Atrophy Treatment Market by Type
7.2.4.7.2 Rest of Europe Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.4.7.3 Rest of Europe Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.4.7.3.1 Rest of Europe Spinal Muscular Atrophy Treatment Market by Drug Type
7.3 Asia Pacific Spinal Muscular Atrophy Treatment Market
7.3.1 Asia Pacific Spinal Muscular Atrophy Treatment Market by Type
7.3.1.1 Asia Pacific Type 1 Market by Country
7.3.1.2 Asia Pacific Type 2 Market by Country
7.3.1.3 Asia Pacific Type 3 Market by Country
7.3.1.4 Asia Pacific Type 4 Market by Country
7.3.2 Asia Pacific Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.2.1 Asia Pacific Injection Market by Country
7.3.2.2 Asia Pacific Oral Market by Country
7.3.3 Asia Pacific Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.3.1 Asia Pacific Drug Market by Country
7.3.3.2 Asia Pacific Spinal Muscular Atrophy Treatment Market by Drug Type
7.3.3.2.1 Asia Pacific Spinraza Market by Country
7.3.3.2.2 Asia Pacific Zolgensma (AVXS-101) Market by Country
7.3.3.2.3 Asia Pacific Evrysdi Market by Country
7.3.3.2.4 Asia Pacific Others Market by Country
7.3.3.3 Asia Pacific Gene Therapy Market by Country
7.3.4 Asia Pacific Spinal Muscular Atrophy Treatment Market by Country
7.3.4.1 China Spinal Muscular Atrophy Treatment Market
7.3.4.1.1 China Spinal Muscular Atrophy Treatment Market by Type
7.3.4.1.2 China Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.4.1.3 China Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.4.1.3.1 China Spinal Muscular Atrophy Treatment Market by Drug Type
7.3.4.2 Japan Spinal Muscular Atrophy Treatment Market
7.3.4.2.1 Japan Spinal Muscular Atrophy Treatment Market by Type
7.3.4.2.2 Japan Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.4.2.3 Japan Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.4.2.3.1 Japan Spinal Muscular Atrophy Treatment Market by Drug Type
7.3.4.3 India Spinal Muscular Atrophy Treatment Market
7.3.4.3.1 India Spinal Muscular Atrophy Treatment Market by Type
7.3.4.3.2 India Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.4.3.3 India Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.4.3.3.1 India Spinal Muscular Atrophy Treatment Market by Drug Type
7.3.4.4 South Korea Spinal Muscular Atrophy Treatment Market
7.3.4.4.1 South Korea Spinal Muscular Atrophy Treatment Market by Type
7.3.4.4.2 South Korea Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.4.4.3 South Korea Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.4.4.3.1 South Korea Spinal Muscular Atrophy Treatment Market by Drug Type
7.3.4.5 Australia Spinal Muscular Atrophy Treatment Market
7.3.4.5.1 Australia Spinal Muscular Atrophy Treatment Market by Type
7.3.4.5.2 Australia Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.4.5.3 Australia Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.4.5.3.1 Australia Spinal Muscular Atrophy Treatment Market by Drug Type
7.3.4.6 Malaysia Spinal Muscular Atrophy Treatment Market
7.3.4.6.1 Malaysia Spinal Muscular Atrophy Treatment Market by Type
7.3.4.6.2 Malaysia Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.4.6.3 Malaysia Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.4.6.3.1 Malaysia Spinal Muscular Atrophy Treatment Market by Drug Type
7.3.4.7 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market
7.3.4.7.1 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Type
7.3.4.7.2 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.4.7.3 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.4.7.3.1 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Drug Type
7.4 LAMEA Spinal Muscular Atrophy Treatment Market
7.4.1 LAMEA Spinal Muscular Atrophy Treatment Market by Type
7.4.1.1 LAMEA Type 1 Market by Country
7.4.1.2 LAMEA Type 2 Market by Country
7.4.1.3 LAMEA Type 3 Market by Country
7.4.1.4 LAMEA Type 4 Market by Country
7.4.2 LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.2.1 LAMEA Injection Market by Country
7.4.2.2 LAMEA Oral Market by Country
7.4.3 LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.3.1 LAMEA Drug Market by Country
7.4.3.2 LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type
7.4.3.2.1 LAMEA Spinraza Market by Country
7.4.3.2.2 LAMEA Zolgensma (AVXS-101) Market by Country
7.4.3.2.3 LAMEA Evrysdi Market by Country
7.4.3.2.4 LAMEA Others Market by Country
7.4.3.3 LAMEA Gene Therapy Market by Country
7.4.4 LAMEA Spinal Muscular Atrophy Treatment Market by Country
7.4.4.1 Brazil Spinal Muscular Atrophy Treatment Market
7.4.4.1.1 Brazil Spinal Muscular Atrophy Treatment Market by Type
7.4.4.1.2 Brazil Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.4.1.3 Brazil Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.4.1.3.1 Brazil Spinal Muscular Atrophy Treatment Market by Drug Type
7.4.4.2 Argentina Spinal Muscular Atrophy Treatment Market
7.4.4.2.1 Argentina Spinal Muscular Atrophy Treatment Market by Type
7.4.4.2.2 Argentina Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.4.2.3 Argentina Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.4.2.3.1 Argentina Spinal Muscular Atrophy Treatment Market by Drug Type
7.4.4.3 UAE Spinal Muscular Atrophy Treatment Market
7.4.4.3.1 UAE Spinal Muscular Atrophy Treatment Market by Type
7.4.4.3.2 UAE Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.4.3.3 UAE Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.4.3.3.1 UAE Spinal Muscular Atrophy Treatment Market by Drug Type
7.4.4.4 Saudi Arabia Spinal Muscular Atrophy Treatment Market
7.4.4.4.1 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Type
7.4.4.4.2 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.4.4.3 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.4.4.3.1 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Drug Type
7.4.4.5 South Africa Spinal Muscular Atrophy Treatment Market
7.4.4.5.1 South Africa Spinal Muscular Atrophy Treatment Market by Type
7.4.4.5.2 South Africa Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.4.5.3 South Africa Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.4.5.3.1 South Africa Spinal Muscular Atrophy Treatment Market by Drug Type
7.4.4.6 Nigeria Spinal Muscular Atrophy Treatment Market
7.4.4.6.1 Nigeria Spinal Muscular Atrophy Treatment Market by Type
7.4.4.6.2 Nigeria Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.4.6.3 Nigeria Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.4.6.3.1 Nigeria Spinal Muscular Atrophy Treatment Market by Drug Type
7.4.4.7 Rest of LAMEA Spinal Muscular Atrophy Treatment Market
7.4.4.7.1 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Type
7.4.4.7.2 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.4.7.3 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.4.7.3.1 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type

Chapter 8. Company Profiles
8.1 PTC Therapeutics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Approvals and Trials:
8.2 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals and Trials:
8.2.5.2 Acquisition and Mergers:
8.3 Biohaven Pharmaceutical Holding Company Ltd. (Pfizer, Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Novartis AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.4.5.2 Acquisition and Mergers:
8.5 Ionis Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.6 Scholar Rock, Inc. (Scholar Rock Holding Corporation)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.7 Cytokinetics, Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Research & Development Expenses
8.8 Astellas Pharma, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.9 Biogen, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.10. NMD Pharma A/S
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Geographical Expansions:

TABLE 1 Global Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 2 Global Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 3 Global Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 4 Global Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 5 Global Type 1 Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Type 1 Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Type 2 Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Type 2 Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Type 3 Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Type 3 Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Type 4 Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Type 4 Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 14 Global Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 15 Global Injection Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Injection Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Oral Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Oral Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 20 Global Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 21 Global Drug Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Drug Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 24 Global Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 25 Global Spinraza Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Spinraza Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Zolgensma (AVXS-101) Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Zolgensma (AVXS-101) Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Evrysdi Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Evrysdi Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Gene Therapy Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Gene Therapy Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Spinal Muscular Atrophy Treatment Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Spinal Muscular Atrophy Treatment Market by Region, 2022 - 2028, USD Million
TABLE 37 North America Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 38 North America Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 39 North America Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 40 North America Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 41 North America Type 1 Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Type 1 Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Type 2 Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Type 2 Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Type 3 Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Type 3 Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Type 4 Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Type 4 Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 50 North America Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 51 North America Injection Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Injection Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Oral Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Oral Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 56 North America Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 57 North America Drug Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Drug Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 60 North America Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 61 North America Spinraza Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Spinraza Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Zolgensma (AVXS-101) Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Zolgensma (AVXS-101) Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Evrysdi Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Evrysdi Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Spinal Muscular Atrophy Treatment Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Spinal Muscular Atrophy Treatment Market by Country, 2022 - 2028, USD Million
TABLE 73 US Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 74 US Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 75 US Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 76 US Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 77 US Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 78 US Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 79 US Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 80 US Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 81 US Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 82 US Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 83 Canada Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 84 Canada Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 85 Canada Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 86 Canada Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 87 Canada Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 88 Canada Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 89 Canada Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 90 Canada Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 91 Canada Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 92 Canada Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 93 Mexico Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 94 Mexico Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 95 Mexico Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 96 Mexico Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 97 Mexico Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 98 Mexico Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 99 Mexico Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 100 Mexico Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 101 Mexico Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 102 Mexico Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 103 Rest of North America Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 104 Rest of North America Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 105 Rest of North America Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 106 Rest of North America Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 107 Rest of North America Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 108 Rest of North America Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 109 Rest of North America Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 110 Rest of North America Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 111 Rest of North America Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 112 Rest of North America Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 113 Europe Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 114 Europe Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 115 Europe Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 116 Europe Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 117 Europe Type 1 Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Type 1 Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Type 2 Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Type 2 Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Type 3 Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Type 3 Market by Country, 2022 - 2028, USD Million
TABLE 123 Europe Type 4 Market by Country, 2018 - 2021, USD Million
TABLE 124 Europe Type 4 Market by Country, 2022 - 2028, USD Million
TABLE 125 Europe Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 126 Europe Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 127 Europe Injection Market by Country, 2018 - 2021, USD Million
TABLE 128 Europe Injection Market by Country, 2022 - 2028, USD Million
TABLE 129 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 130 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 131 Europe Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 132 Europe Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 133 Europe Drug Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Drug Market by Country, 2022 - 2028, USD Million
TABLE 135 Europe Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 136 Europe Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 137 Europe Spinraza Market by Country, 2018 - 2021, USD Million
TABLE 138 Europe Spinraza Market by Country, 2022 - 2028, USD Million
TABLE 139 Europe Zolgensma (AVXS-101) Market by Country, 2018 - 2021, USD Million
TABLE 140 Europe Zolgensma (AVXS-101) Market by Country, 2022 - 2028, USD Million
TABLE 141 Europe Evrysdi Market by Country, 2018 - 2021, USD Million
TABLE 142 Europe Evrysdi Market by Country, 2022 - 2028, USD Million
TABLE 143 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 144 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 145 Europe Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 146 Europe Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 147 Europe Spinal Muscular Atrophy Treatment Market by Country, 2018 - 2021, USD Million
TABLE 148 Europe Spinal Muscular Atrophy Treatment Market by Country, 2022 - 2028, USD Million
TABLE 149 Germany Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 150 Germany Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 151 Germany Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 152 Germany Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 153 Germany Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 154 Germany Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 155 Germany Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 156 Germany Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 157 Germany Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 158 Germany Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 159 UK Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 160 UK Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 161 UK Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 162 UK Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 163 UK Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 164 UK Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 165 UK Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 166 UK Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 167 UK Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 168 UK Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 169 France Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 170 France Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 171 France Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 172 France Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 173 France Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 174 France Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 175 France Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 176 France Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 177 France Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 178 France Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 179 Russia Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 180 Russia Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 181 Russia Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 182 Russia Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 183 Russia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 184 Russia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 185 Russia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 186 Russia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 187 Russia Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 188 Russia Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 189 Spain Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 190 Spain Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 191 Spain Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 192 Spain Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 193 Spain Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 194 Spain Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 195 Spain Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 196 Spain Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 197 Spain Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 198 Spain Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 199 Italy Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 200 Italy Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 201 Italy Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 202 Italy Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 203 Italy Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 204 Italy Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 205 Italy Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 206 Italy Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 207 Italy Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 208 Italy Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 209 Rest of Europe Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 210 Rest of Europe Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 211 Rest of Europe Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 212 Rest of Europe Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 213 Rest of Europe Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 214 Rest of Europe Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 215 Rest of Europe Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 216 Rest of Europe Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 217 Rest of Europe Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 218 Rest of Europe Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 219 Asia Pacific Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 220 Asia Pacific Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 221 Asia Pacific Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 222 Asia Pacific Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 223 Asia Pacific Type 1 Market by Country, 2018 - 2021, USD Million
TABLE 224 Asia Pacific Type 1 Market by Country, 2022 - 2028, USD Million
TABLE 225 Asia Pacific Type 2 Market by Country, 2018 - 2021, USD Million
TABLE 226 Asia Pacific Type 2 Market by Country, 2022 - 2028, USD Million
TABLE 227 Asia Pacific Type 3 Market by Country, 2018 - 2021, USD Million
TABLE 228 Asia Pacific Type 3 Market by Country, 2022 - 2028, USD Million
TABLE 229 Asia Pacific Type 4 Market by Country, 2018 - 2021, USD Million
TABLE 230 Asia Pacific Type 4 Market by Country, 2022 - 2028, USD Million
TABLE 231 Asia Pacific Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 232 Asia Pacific Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 233 Asia Pacific Injection Market by Country, 2018 - 2021, USD Million
TABLE 234 Asia Pacific Injection Market by Country, 2022 - 2028, USD Million
TABLE 235 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 236 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 237 Asia Pacific Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 238 Asia Pacific Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 239 Asia Pacific Drug Market by Country, 2018 - 2021, USD Million
TABLE 240 Asia Pacific Drug Market by Country, 2022 - 2028, USD Million
TABLE 241 Asia Pacific Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 242 Asia Pacific Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 243 Asia Pacific Spinraza Market by Country, 2018 - 2021, USD Million
TABLE 244 Asia Pacific Spinraza Market by Country, 2022 - 2028, USD Million
TABLE 245 Asia Pacific Zolgensma (AVXS-101) Market by Country, 2018 - 2021, USD Million
TABLE 246 Asia Pacific Zolgensma (AVXS-101) Market by Country, 2022 - 2028, USD Million
TABLE 247 Asia Pacific Evrysdi Market by Country, 2018 - 2021, USD Million
TABLE 248 Asia Pacific Evrysdi Market by Country, 2022 - 2028, USD Million
TABLE 249 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 250 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 251 Asia Pacific Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 252 Asia Pacific Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 253 Asia Pacific Spinal Muscular Atrophy Treatment Market by Country, 2018 - 2021, USD Million
TABLE 254 Asia Pacific Spinal Muscular Atrophy Treatment Market by Country, 2022 - 2028, USD Million
TABLE 255 China Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 256 China Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 257 China Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 258 China Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 259 China Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 260 China Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 261 China Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 262 China Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 263 China Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 264 China Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 265 Japan Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 266 Japan Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 267 Japan Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 268 Japan Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 269 Japan Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 270 Japan Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 271 Japan Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 272 Japan Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 273 Japan Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 274 Japan Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 275 India Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 276 India Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 277 India Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 278 India Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 279 India Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 280 India Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 281 India Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 282 India Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 283 India Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 284 India Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 285 South Korea Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 286 South Korea Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 287 South Korea Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 288 South Korea Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 289 South Korea Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 290 South Korea Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 291 South Korea Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 292 South Korea Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 293 South Korea Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 294 South Korea Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 295 Australia Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 296 Australia Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 297 Australia Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 298 Australia Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 299 Australia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 300 Australia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 301 Australia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 302 Australia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 303 Australia Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 304 Australia Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 305 Malaysia Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 306 Malaysia Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 307 Malaysia Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 308 Malaysia Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 309 Malaysia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 310 Malaysia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 311 Malaysia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 312 Malaysia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 313 Malaysia Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 314 Malaysia Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 315 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 316 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 317 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 318 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 319 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 320 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 321 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 322 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 323 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 324 Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 325 LAMEA Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 326 LAMEA Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 327 LAMEA Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 328 LAMEA Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 329 LAMEA Type 1 Market by Country, 2018 - 2021, USD Million
TABLE 330 LAMEA Type 1 Market by Country, 2022 - 2028, USD Million
TABLE 331 LAMEA Type 2 Market by Country, 2018 - 2021, USD Million
TABLE 332 LAMEA Type 2 Market by Country, 2022 - 2028, USD Million
TABLE 333 LAMEA Type 3 Market by Country, 2018 - 2021, USD Million
TABLE 334 LAMEA Type 3 Market by Country, 2022 - 2028, USD Million
TABLE 335 LAMEA Type 4 Market by Country, 2018 - 2021, USD Million
TABLE 336 LAMEA Type 4 Market by Country, 2022 - 2028, USD Million
TABLE 337 LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 338 LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 339 LAMEA Injection Market by Country, 2018 - 2021, USD Million
TABLE 340 LAMEA Injection Market by Country, 2022 - 2028, USD Million
TABLE 341 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 342 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 343 LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 344 LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 345 LAMEA Drug Market by Country, 2018 - 2021, USD Million
TABLE 346 LAMEA Drug Market by Country, 2022 - 2028, USD Million
TABLE 347 LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 348 LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 349 LAMEA Spinraza Market by Country, 2018 - 2021, USD Million
TABLE 350 LAMEA Spinraza Market by Country, 2022 - 2028, USD Million
TABLE 351 LAMEA Zolgensma (AVXS-101) Market by Country, 2018 - 2021, USD Million
TABLE 352 LAMEA Zolgensma (AVXS-101) Market by Country, 2022 - 2028, USD Million
TABLE 353 LAMEA Evrysdi Market by Country, 2018 - 2021, USD Million
TABLE 354 LAMEA Evrysdi Market by Country, 2022 - 2028, USD Million
TABLE 355 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 356 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 357 LAMEA Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 358 LAMEA Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 359 LAMEA Spinal Muscular Atrophy Treatment Market by Country, 2018 - 2021, USD Million
TABLE 360 LAMEA Spinal Muscular Atrophy Treatment Market by Country, 2022 - 2028, USD Million
TABLE 361 Brazil Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 362 Brazil Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 363 Brazil Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 364 Brazil Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 365 Brazil Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 366 Brazil Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 367 Brazil Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 368 Brazil Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 369 Brazil Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 370 Brazil Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 371 Argentina Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 372 Argentina Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 373 Argentina Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 374 Argentina Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 375 Argentina Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 376 Argentina Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 377 Argentina Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 378 Argentina Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 379 Argentina Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 380 Argentina Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 381 UAE Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 382 UAE Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 383 UAE Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 384 UAE Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 385 UAE Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 386 UAE Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 387 UAE Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 388 UAE Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 389 UAE Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 390 UAE Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 391 Saudi Arabia Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 392 Saudi Arabia Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 393 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 394 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 395 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 396 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 397 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 398 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 399 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 400 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 401 South Africa Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 402 South Africa Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 403 South Africa Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 404 South Africa Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 405 South Africa Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 406 South Africa Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 407 South Africa Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 408 South Africa Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 409 South Africa Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 410 South Africa Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 411 Nigeria Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 412 Nigeria Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 413 Nigeria Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 414 Nigeria Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 415 Nigeria Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 416 Nigeria Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 417 Nigeria Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 418 Nigeria Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 419 Nigeria Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 420 Nigeria Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 421 Rest of LAMEA Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 422 Rest of LAMEA Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 423 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 424 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 425 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 426 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 427 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 428 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 429 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 430 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 431 Key Information – PTC Therapeutics, Inc.
TABLE 432 key information – F. Hoffmann-La Roche Ltd.
TABLE 433 Key Information – Biohaven Pharmaceutical Holding Company Ltd.
TABLE 434 Key Information – Novartis AG
TABLE 435 Key information – Ionis Pharmaceuticals, Inc.
TABLE 436 Key Information – Scholar Rock, Inc.
TABLE 437 Key Information – CYTOKINETICS, INCORPORATED
TABLE 438 key information – Astellas Pharma, Inc.
TABLE 439 Key Information – Biogen, Inc.
TABLE 440 Key Information – nmd pharma a/s

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Spinal Muscular Atrophy Treatment Market Share by Type, 2021
FIG 3 Global Spinal Muscular Atrophy Treatment Market Share by Type, 2028
FIG 4 Global Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2028, USD Million
FIG 5 Global Spinal Muscular Atrophy Treatment Market Share by Route of Administration, 2021
FIG 6 Global Spinal Muscular Atrophy Treatment Market Share by Route of Administration, 2028
FIG 7 Global Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2028, USD Million
FIG 8 Global Spinal Muscular Atrophy Treatment Market Share by Treatment Type, 2021
FIG 9 Global Spinal Muscular Atrophy Treatment Market Share by Treatment Type, 2028
FIG 10 Global Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2028, USD Million
FIG 11 Global Spinal Muscular Atrophy Treatment Market Share by Region, 2021
FIG 12 Global Spinal Muscular Atrophy Treatment Market Share by Region, 2028
FIG 13 Global Spinal Muscular Atrophy Treatment Market by Region, 2018 - 2028, USD Million
FIG 14 Recent strategies and developments: PTC Therapeutics, Inc.